WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King joined a bipartisan group of colleagues in advocating for American dairy farmers and calling out the Food and Drug Administration (FDA) for letting non-dairy lab-grown products illegally label their products with dairy terms. The bipartisan group highlighted the proliferation of imitation products, specifically the new cell-based, lab-grown imitators that are using dairy terms like milk, cheese and yogurt.

“For decades FDA has allowed non-dairy products to illegally use dairy terms to label their imitation products, most of which are nutritionally inferior to the real dairy foods they purport to emulate,” wrote the Senators in a letter to FDA Commissioner Robert Califf. “Public health is now facing a new, additional perpetrator – Cell-based dairy imitation products. These are synthetically created options posing as natural foods, many of which are nutritionally inferior to the dairy products they imitate.”

Current FDA regulations define dairy products as being from dairy animals, however, the FDA has failed to enforce these regulations, allowing non-dairy products to use dairy names, leading to the rapid growth of mislabeled alternative products that contain a range of ingredients and nutrients that are often not equivalent to the nutritional content of dairy products – including cell-based, synthetic dairy imitation products. By using dairy names like milk, these synthetic products are posing as natural foods, clearly violating the FDA’s standards of identity, which requires the food product be made from milk from an animal.

“It is critical that FDA intervene to prevent this new violation committed by cell-based foods from compounding the harm Americans are already experiencing from FDA’s decades of inaction on plant-based mislabeling,” wrote the Senators. “New developments in food science should advance new and innovative products, not cause deeper injury to public health. It is FDA’s job to ensure a stable and transparent marketplace to support safe innovation while protecting Americans.”

Maine dairy farmers and creameries provide 4,733 direct and 10,201 indirect jobs and generate $904 million in direct economic impact and $1 billion in indirect economic impact.

Senators Collins and King previously introduced the bipartisan DAIRY PRIDE Act to combat the mislabeling of non-dairy products like nut, oat, soy, and, now, lab grown options. Their legislation would require non-dairy products to no longer be mislabeled with terms such as milk, yogurt or cheese.

The letter was co-signed by Senators Tammy Baldwin (D-Wis.), Jim Risch (R-Idaho), Kirsten Gillibrand (D-N.Y.), Tina Smith (D-Minn.), Roger Marshall (R-Kansas), and Mike Crapo (R-Idaho).

The full letter is available here and below. An online version of this release is available here.

+++

Dear Commissioner Califf,

We share with you a dedication to ensuring a safe and honest marketplace that furthers the health and well-being of all Americans. From this shared commitment, we write today to again voice our strong concerns over the Food and Drug Administration’s lack of enforcement of dairy standards of identity and bring to your attention the emergence of cell-based imitation products to market.

For decades FDA has allowed non-dairy products to illegally use dairy terms to label their imitation products, most of which are nutritionally inferior to the real dairy foods they purport to emulate. Americans rely on FDA for marketplace safety and transparency, both of which are vital for Americans to make informed decisions about their health and the health of their families. After decades of FDA allowing this blatant mislabeling, demonstrated confusion over the nutritional content of dairy imitators has medical and health professionals documenting the real harm and public health concerns of FDA continuing to fail to enforce.¹ FDA’s lack of enforcement is failing the American public.

Public health is now facing a new, additional perpetrator – Cell-based dairy imitation products. These are synthetically created options posing as natural foods, many of which are nutritionally inferior to the dairy products they imitate. Their use of dairy terms is another clear violation of FDA’s standards of identity, which requires the food product be made from milk from an animal.

It is critical that FDA intervene to prevent this new violation committed by cell-based foods from compounding the harm Americans are already experiencing from FDA’s decades of inaction on plant-based mislabeling.

New developments in food science should advance new and innovative products, not cause deeper injury to public health. It is FDA’s job to ensure a stable and transparent marketplace to support safe innovation while protecting Americans, and Congress has ensured FDA has the resources to do so. We strongly urge you, as FDA Commissioner, to enforce dairy standards of identity and stop synthetic imitation products from using dairy terms.

Sincerely,

###